ObjectiveTo develop a Spanish language tool for acute stroke identification.MethodsA Spanish language translation of the Balance-Eyes-Face-Arm-Speech-Time tool was developed within our emergency medical services agency.ResultsThe authors present a new prehospital stroke tool, Andar, Hablar, Ojos, Rostro and Ambos Brazos o Piernas (AHORA) (which means now in Spanish) to help combat the language barrier and reinforce the necessity to call 9-1-1 as soon as any stroke symptoms are noted.ConclusionAHORA is a Spanish language tool that aims to help Spanish-speaking individuals to identify an acute stroke and obtain prompt help.
frequency of CBI in patients undergoing computed tomography (CT) in the ED and to determine how often clinicians act on these findings or make patients aware of them.Methods: All patients over 50 years of age who underwent a non-contrast enhanced head CT in the ED from January to August 2018 were identified. Patients with a history of stroke, or prior brain imaging with any ischemia, were excluded, as were patients admitted to the hospital. Clinical data, including patient history and presence of CBI, were noted. Medical records were reviewed to determine whether the patients with CBI were informed of the finding, either verbally as documented or in their discharge instructions. Subsequent interventions for CBI patients were noted (neurology consultation or medication adjustment).Results: A total of 832 patients were included in our analysis. The average age was 62 years and 50% were female (Table 1). CBI were present in 11% of patients (n¼95). Patients with CBI were older and more likely to have hypertension. Only 9% (n¼9) of CBI patients were clearly made aware of the finding. Of the patients with CBI, 27% (n ¼ 26) were already on aspirin and 28% (n¼27) on a statin. Of those not on medication, aspirin was added in 2 patients and blood pressure medication was added or adjusted in 2 patients. A statin medication was not started on any patients with CBI. Neurology consult was obtained in 9% (n¼9) of patients with CBI, of whom 2 were made aware of the findings.Conclusion: The prevalence of CBI in patients over 50 presenting to the ED who undergo head CT and are subsequently discharged from the ED is 11%. Only 9% of these patients were made aware of the finding, with minimal intervention for stroke prevention at the time of their visit. Interventions targeting this population should be considered. 2021 Research Forum Abstracts S10 Annals of Emergency Medicine Volume 78, no. 4s : October 2021 * Significant comparison at p<0.05 versus no anticoagulant or antiplatelet group. † P2Y12 inhibitors include clopidogrel (n=33) and ticagrelor (n=2). ‡ Factor Xa inhibitors includes apixaban (n=36) and rivaroxaban (n=31). § Heparin includes unfractionated heparin (n=1) and enoxaparin (n=4).
AHORA (Andar, Hablar, Ojos, Rostro, Ambos Brazos o Piernas) is a Spanish language tool to identify stroke symptoms. A survey of 300 primarily Spanish-speaking, non-medical professionals was conducted to assess the acceptance of the tool, specifically about ease of understanding and ability to implement it. The overwhelming majority of respondents reacted very positively to the tool, finding it quite easy to learn, teach, and understand. Respondent feedback, pitfalls, and questions for further research are presented.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.